Epic Sciences

07.07.2016 / New York / GenomeWeb Back to News Listings

Genomic Health to market Epic Sciences’ AR-V7 liquid biopsy test.

Genomic Health and Epic Sciences today announced that they have signed an exclusive agreement under which Genomic Health will commercialize Epic Sciences' AR-V7 liquid biopsy test in the United States.

Read the entire story on GenomeWeb.


genomeweb-logo_2x.jpg